Division of Cancer Epidemiology & Genetics

Publications

Scientists Uncover Potential Biomarker for HPV-Related Oropharynx Cancer

DCEG investigators and collaborators found that HPV antibodies may help identify individuals who are at greatly increased risk of HPV-related cancer of the oropharynx.

•	Read the NCI press release for the study
•	Learn more about Dr. Aimée Kreimer

Newly Tenured: Nicolas Wentzensen

Dr. Nicolas Wentzensen is now a Senior Investigator in the Hormonal and Reproductive Epidemiology Branch.

•	Read an article about his research in Linkage
•	See Dr. Wentzensen's bio page

Understanding the Risks of Medical Radiation

Teams of epidemiologists, radiation dosimetrists, and statisticians in DCEG's Radiation Epidemiology Branch uncover the cancer risks associated with low-dose diagnostic and screening procedures and high-dose radiation therapy.

•	Read the full article in the March 2013 Linkage

Biomarker for HPV-Related Oropharynx Cancer
Newly Tenured: Nicolas Wentzensen
Understanding the Risks of Medical Radiation

The Division of Cancer Epidemiology and Genetics (DCEG) is a research program of the National Cancer Institute (NCI), one of the National Institutes of Health (NIH). The Division is the world’s most comprehensive cancer epidemiology research group. Its renowned epidemiologists, geneticists, and biostatisticians conduct population and multidisciplinary research to discover the genetic and environmental determinants of cancer and new approaches to cancer prevention. The Division’s research impacts public health policy in the United States and around the world.

Linkage Newsletter